#HeFH #PCSK9 #lipids #cardiology #clinicaltrials #cholesterol #LDL #preventivecardiology To view or add a comment, sign in A novel medication, DR10624, has demonstrated significant potential in managing severe hypertriglyceridemia during a recent Phase 2 clinical trial
Our medical weight loss programs are made to provide safe, effective, and sustainable results
The SURMOUNT clinical trial series demonstrated that adults receiving tirzepatide injections lost 2022% of baseline body weight over 68 weeks, compared to 23% with placebo
#Obesity #GLP1 #BehaviouralMedicine #dietetics To view or add a comment, sign in New consensus statement, out this week in The Lancet Diabetes & Endocrinology, from European Association for the Study of Obesity (EASO), The European Federation of the Associations of Dietitians (EFAD) and ECPObesity: "Nutritional, functional, and psychological considerations for incretin-based therapies in adults." Link in comments
Whilst mild cold sensitivity may occur during weight loss with tirzepatide, certain circumstances warrant medical review
A faint headspace odor can be harmless, but a strong or persistent L-carnitine smell with visual changes is a red flag
